Accelerating Medicines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Researchers made a significant breakthrough in Alzheimer's disease research by identifying a novel way to potentially slow down or even halt disease progression. The study, which focuses on the role of reactive astrocytes and the plexin-B1 protein in Alzheimer's pathophysiology, provides crucial insights into brain cell communication and opens the door to innovative treatment strategies.

Researchers want to streamline the drug development process to reduce costs and enable companies to bring more gene therapies to patients.

As part of the Foundation for the National Institutes of Health Accelerating Medicines Partnership Bespoke Gene Therapy Consortium, Nemours Children's Health has been chosen to conduct a first-of-its-kind gene therapy clinical trial for Morquio A syndrome.

Invasive kidney biopsy has been the mainstay for lupus nephritis management. Investigators are currently looking for noninvasive markers.